On ECHEMI
Home > Drugs > Pulmonary cryptococcosis
Pulmonary cryptococcosis
Pulmonary cryptococcosis is a subacute or chronic visceral fungal disease caused by new cryptococcal infection. This fungus belongs to the saprophytic yeast, does not form hyphae and spores, and is widely present in nature. Low immune function is the main cause of the disease. The fungus is mostly inhaled into the human body through the respiratory tract and forms infection foci in the lungs. It mainly invades the lungs and central nervous system, but can also invade bones, skin, mucous membranes and other organs. Healthy people can usually recover on their own after infection or the lesions are limited to the lungs, without clinical symptoms. When the resistance is reduced, it will cause the disease and can spread to the whole body through blood. The central nervous system is most likely to be affected, so cryptococcal meningitis and pneumonia are often suffered at the same time.
  • Site of disease:

    lung
  • Infectious :

    Contagious
  • Frequent population:

    AIDS patients
  • Related symptoms:

    Cough sputum is mucopurulent low fever dyspnea cryptococcal capsular polysaccharide accumulation
  • Concurrent disease:

Related Drugs
Cisulan Tablets
Indication: It can relieve cough, eliminate phlegm and reduce inflammation. It is used for acute and chronic upper respiratory tract infections and lung infections.
Manufacturer:

NORTHEAST Pharmaceutical Group Shenyang NO.1 Pharmaceutical Co., Ltd.

Cefadroxil Capsules
Indication: It is suitable for urinary tract infections, skin and soft tissue infections, acute tonsillitis, acute pharyngitis, otitis media and lung infections caused by sensitive bacteria. This product is an oral preparation and should not be used for severe infections.
Manufacturer:

Tianjin Huajin Pharmaceutcial Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.